Evolent Health Inc (EVH) — Cash Flow-to-Debt Ratio
Evolent Health Inc (EVH) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of $-984.00K could theoretically repay 0% of its total liabilities ($1.48 Billion) in one year. See EVH free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Evolent Health Inc Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Evolent Health Inc across 14 annual periods. Also explore EVH net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Evolent Health Inc (2012–2025)
Year-by-year debt coverage analysis for Evolent Health Inc. For market capitalisation and broader financial context, see EVH market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | $38.84 Million | $1.48 Billion | ▲ +115.2% |
| 2024 | 0.01x | $18.77 Million | $1.54 Billion | ▼ -86.2% |
| 2023 | 0.09x | $142.58 Million | $1.61 Billion | ▲ +833.1% |
| 2022 | -0.01x | $-11.55 Million | $957.88 Million | ▼ -122.6% |
| 2021 | 0.05x | $38.75 Million | $725.83 Million | ▲ +381.3% |
| 2020 | -0.02x | $-16.23 Million | $854.84 Million | ▲ +74.7% |
| 2019 | -0.07x | $-42.65 Million | $568.97 Million | ▼ -93.4% |
| 2018 | -0.04x | $-20.65 Million | $532.92 Million | ▲ +63.1% |
| 2017 | -0.10x | $-27.96 Million | $266.39 Million | ▲ +15.0% |
| 2016 | -0.12x | $-35.51 Million | $287.73 Million | ▲ +49.6% |
| 2015 | -0.24x | $-19.83 Million | $80.94 Million | ▲ +86.8% |
| 2014 | -1.86x | $-75.09 Million | $40.35 Million | ▼ -868.6% |
| 2013 | -0.19x | $-13.63 Million | $70.93 Million | ▲ +83.3% |
| 2012 | -1.15x | $-12.77 Million | $11.10 Million | — |